AINDEX
Markets

Cardiol Therapeutics Inc. (CRDL)

CRDLNASDAQ-CMBiotechnology: Biological Products (No Diagnostic Substances)

$0.9801

+0.0083 (+0.85%) today

At the close, Nov 18, 4:00 PM ET. After hours $0.9900 +4.20%

+0.85% 1D
Market cap
$121.32m
P/E
–
EPS, last 4 quarters
$-0.2400
Dividend yield
–
Day range
$0.9300 to $0.9900
52-week range
$0.8800 to $2.34
Average volume
–
Previous close
$0.9718

Analysts

3 covering

Buy3 buy, 0 hold, 0 sell

Targets a year out average $10.00, +920.3% from here

$9.00now $0.9801$11.00

Earnings

next estimate $-0.0500

Next report

Dec 2025

+44.4%

Mar 2026

0.0%

Jun 2026

+55.6%

Sep 2026

-33.3%

estimate reported, and the surprise

Financials

No quarterly figures from the source.

News

8 latest

The company

Cardiol Therapeutics Inc. is a late-stage life sciences company focused on advancing the development of anti-inflammatory and anti-fibrotic therapies for heart disease.

Sector
Health Care
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Exchange
NASDAQ-CM
Region
North America

Often looked at with it

Figures from Yahoo, Nasdaq (Zacks consensus) and Lighter. Stocks can be minutes behind. Nothing here is advice.